Chemical Compound

gliclazide

CAS Registry Number 21187-98-4
Back to search Request a Quote
gliclazide chemical structure
Primary Record

gliclazide

In stock
5,747 g
Purity
99.4 %
CAS
21187-98-4

Compound Identifiers & Properties

CAS
21187-98-4
PubChem CID
3475
SMILES
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2
Canonical SMILES
Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1

Names & Synonyms

  • gliclazide
  • Glimicron
  • Diamicron
  • 21187-98-4
  • Gliclazida
  • Glyclazide
  • Gliklazid
  • Nordialex
  • Diaikron
  • Diabrezide
  • Gliclazidum
  • Novo Gliclazide
  • Gen Gliclazide
  • Gliclazide?
  • diabezidum
  • diabyl
  • diaprel
  • dizalid
  • gliclazid
  • glinormax
  • glyzide
  • Diamicron MR
  • Benelaxa
  • Crawnart
  • Diaglico
  • Glimiran
  • Glutameal
  • Kyowacron
  • Ruimenia
  • Ziclaseg
  • Bilxona
  • Diaglyk
  • Edicil
  • Glimil
  • Glyade
  • Zicron
  • Unava
  • Vamju
  • Novo-Gliclazide
  • Diabrezide;
  • Gen-Gliclazide
  • Glyclazide;
  • Dacadis mr
  • Diamicron;
  • Glimicron;
  • Nordialex;
  • Nazdol mr
  • Vitile xl
  • Zicron pr
  • Glimicron (TN)
  • Mylan-Gliclazide
  • Gliclazide CRS
  • Gliclazide-d4
  • Glimicron HA
  • PMS-Gliclazide
  • Diamicron (TN)
  • Gliclazidum [INN-Latin]
  • Gliclazida [INN-Spanish]
  • Prestwick_869
  • Dianorm (TN)
  • Glubitor-OD (TN)
  • Gliclazide (Standard)
  • C15H21N3O3S
  • Gliclazide (Diamicron)
  • Spectrum_001478
  • SpecPlus_000870
  • DTXSID9023095
  • Gliclazide (JAN/INN)
  • Prestwick0_000558
  • Prestwick1_000558
  • Prestwick2_000558
  • Prestwick3_000558
  • RefChem:389010
  • Spectrum3_001862
  • Spectrum4_000598
  • Spectrum5_000753
  • G4PX8C4HKV
  • CHEBI:31654
  • D0M2MR
  • Gliclazide (JP18/INN)
  • AC1L1G0Q
  • BOVGTQGAOIONJV-UHFFFAOYSA-N
  • DTXCID003095
  • SE 1702
  • MFCD00409893
  • SCHEMBL16387
  • BSPBio_000635
  • BSPBio_003304
  • KBioGR_001096
  • KBioSS_001958
  • MLS001215197
  • MLS001304077
  • MLS001304118
  • DivK1c_006966
  • Gliclazide, powder, >=98%
  • SPECTRUM1504145
  • SPECTRUM1505013
  • Gliclazide [BAN:INN:DCF:JAN]
  • S-852
  • SPBio_002556
  • BPBio1_000699
  • CHEMBL427216
  • orb1308313
  • NSC-758673
  • S-1702
  • CTK7G8576
  • ERK5-6O07
  • HY-B0753R
  • J3.151H
  • KBio1_001910
  • KBio2_001958
  • KBio2_004526
  • KBio2_007094
  • KBio3_002806
  • SE-1702
  • A10BB09
  • CID3475
  • Gliclazide (S1702; Diamicron)
  • HMS1569P17
  • HMS1922D15
  • HMS2090K16
  • HMS2096P17
  • HMS2855P09
  • HMS3656C22
  • HMS3713P17
  • HMS3744O13
  • HMS5081J09
  • Pharmakon1600-01504145
  • S 1702
  • S 852
  • BCP21240
  • CID:3475
  • HY-B0753
  • MSK10066
  • EINECS 244-260-5
  • Tox21_110590
  • ANW-43362
  • BBF-05867
  • BBL012275
  • BDBM50103512
  • EBC-80093
  • NSC758673
  • NSC813216
  • s2601
  • SBB066074
  • STK803142
  • 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea
  • S1702;SE1702
  • S852
  • AKOS003237903
  • AKOS016340698
  • Tox21_110590_1
  • AB05958
  • ACN-040058
  • CCG-213918
  • CS-2963
  • DB01120
  • FG23666
  • KS-1067
  • NSC-813216
  • RP17658
  • BRN 1657836
  • 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
  • NCGC00016751-01
  • NCGC00095107-01
  • NCGC00095107-02
  • NCGC00095107-03
  • NCGC00095107-04
  • NCGC00095107-05
  • NCGC00095107-06
  • NCGC00095107-09
  • NCGC00095107-10
  • S1702
  • 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-p-tolylsulphonylurea
  • AC-12045
  • AN-17308
  • SMR000542971
  • ST076805
  • SBI-0052662.P002
  • SID:134223040
  • AB0012093
  • AB1004595
  • CAS-21187-98-4
  • LS-160299
  • 1-[3-Azabicyclo[3.3.0]oct-3-yl]-3-p-toluenesulfonylurea
  • AB00053165
  • AK00386162
  • FT-0626712
  • G0381
  • NS00002064
  • SW196994-3
  • 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea
  • D01599
  • D83168
  • K-6100
  • AB00053165-09
  • AB00053165_10
  • AB00053165_11
  • EN300-7359575
  • N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea
  • 1-[(4-methylbenzene)sulfonyl]-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea
  • 187G984
  • A815188
  • D005907
  • Q290001
  • SR-01000816184
  • 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(4-methylphenyl)sulfonyl]urea
  • I06-0117
  • N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide
  • SR-01000816184-2
  • SR-01000816184-3
  • SR-01000816184-4
  • Benzenesulfonamide,N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-
  • BRD-A61154809-001-04-3
  • BRD-A61154809-001-14-2
  • BRD-A61154809-001-15-9
  • BRD-A61154809-001-16-7
  • N-((hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide
  • 1-(3-azabicyclo[3.3.0]oct-3-yl)-3-(p-tolylsulfonyl)urea
  • 1-(4-methylbenzenesulfonyl)-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea
  • Benzenesulfonamide, N-(((hexahydrocyclopenta(c)pyrrol-2(1H)-yl)amino)carbonyl)-4-methyl-
  • Benzenesulfonamide, N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-
  • Gliclazide, British Pharmacopoeia (BP) Reference Standard
  • Gliclazide, European Pharmacopoeia (EP) Reference Standard
  • 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(p-tolylsulfonyl)urea
  • 1-(3-Azabicyclo[3.3.0]octan-3-yl)-3-(4-methylphenylsulfonyl)urea
  • N-[(hexahydrocyclopenta[c]pyrrol-2(1H)-ylamino)carbonyl]-4-methylbenzenesulfonamide
  • 1-((4-methylbenzene)sulfonyl)-3-(octahydrocyclopenta(c)pyrrol-2-yl)urea
  • 3-{hexahydro-1H-cyclopenta[c]pyrrol-2-yl}-1-(4-methylbenzenesulfonyl)urea
  • Urea, 1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-
  • Urea, 1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-
  • [(3-azabicyclo[3.3.0]oct-3-yl)amino]-N-[(4-methylphenyl)sulfonyl]carboxamide
  • 1-(3,3a,4,5,6,6a-Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
  • 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-((4-methylphenyl)sulfonyl)urea
  • Gliclazide, 99%, whole-cell beta-cell ATP-sensitive potassium currents blocker - 25G 25g
  • N-(3-azabicyclo[3.3.0]oct-3-yl){[(4-methylphenyl)sulfonyl]amino}carboxamide
  • N-[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl]-4-methylbenzene-1-sulfonamide
  • N-[[(H exahydrocylopenta[c]pyrrol-2(1H)-yl]amino]carbonyl ]-4-methylbenzenesulfonamide
  • N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methylbenzenesulfonamide
  • S-1702; S-852; S1702; S852; S 1702; S 852; SE1702
  • 1185039-30-8
  • 244-260-5
  • BENZENESULFONAMIDE, N-[[(HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-4-METHYL
  • Gliclazide; N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methylbenzenesulfonamide; 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Cyclopenta[c]pyrrole benzenesulfonamide deriv.; 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diabezidum; Diabrezide; Diamicron; Diaprel; Glimicron; Glinormax; Glyzide; N-(4-Methylbenzenesulfonyl)-N'-[3-azabicyclo(3,3,0)oct-3-yl]urea; S 1702; S 852; SE 1702
  • N-[[3,3a,4,5,6,6a-Hexahydrocyclopenta[c]pyrrol-2(1H)-yl]aminocarbonyl]-4-methylbenzenesulfonamide